Dato’ Doctor Mohamed Ibrahim Bin Dato’ Hj. Abdul Wahid
Board of Advisor at Precision Diagnostics
DPMP, MBBCh (Wales), DMRT (UK), FAM (Mal)
Dato’ Dr. Hj. Mohamed Ibrahim Bin Dato’ Hj. Abdul Wahid is currently serving as the Vice President of the College of Radiology. He served as the Past Vice President of the Radiology, Malaysia, Past President of the Malaysian Oncology Society and the Past President of the Asian and Pacific Federation of Cancer Research & Control (APFOCC) and Immediate Past President of South East Asia Radiation Oncology Group (SEAROG). He also frequently gives talks at many international oncology conferences located in Vietnam, Cambodia, Indonesia and Malaysia as his experience in developing multiple oncology centres with cutting-edge technologies, especially in Nepal, Brunei and Myanmar, by providing advice to the following centres.
Dato’ Dr. Hj. Mohamed Ibrahim is a highly skilled medical professional with a solid foundation in Clinical Oncology [DPMP, MBBCH (Wales), DMRT (UK), FAM (Mal)]. Extensive experience in Radiotherapy from the USA, complemented by a comprehensive understanding of medical guidelines and best practices. Hence, he is actively involved in clinical trials and invited by pharmaceutical companies to share his experiences in chemotherapy and targeted agents.
Dato' Dr. Hj. Mohamed Ibrahim is known for his publications – “Patient Guidelines to Radiation Therapy”, including his involvement in multiple Clinical Oncology journals from recent years. Dedicated his research to multiple associations such as AstraZeneca, Roche, Pfizer, and global associations.
Professional Qualifications
- Board of Advisor | Precision Diagnostics (PD)
- Advisor | Precision Medicine and Scientific Wellness (PMedS) Association
- Consultant Clinical Oncologist | Beacon Hospital
- Visiting Consultant Clinical Oncologist | Pantai Hospital Kuala Lumpur
- Vice President | Selangor and Federal Territory Association for the Mentally Handicapped Association
Featuring
PRECISE Pharmacogenomics
Using Genome-wide technology, we can determine how genetic information affects your body’s response to medication through our DNA Test Kit. Our report supports clinicians in providing Clinical Recommendations and Personalized Targeted Treatments. Find out more about Malaysia’s 1st Genome-wide Pharmacogenomic Report Accredited PRECISE Pharmacogenomics!
- Covers more than > 1,000+ genes
- 20+ Therapeutics Areas & 500+ Medications
- Clinical Accredited & Recommended
- Maximise & Optimise Medication Effectiveness